Clinical Trials · NCT06217770
Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Chinese University of Hong Kong
- Enrollment
- 237
- Start date
- Apr 2023
- Locations
- 1 site, Hong Kong
- Primary endpoint
- The usage pattern of the long-acting Gonadotropin-releasing Hormone Agonist agonist triptorelin in real-life clinical practice